These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

329 related items for PubMed ID: 18973889

  • 1. The effects of oral contraceptives including low-dose estrogen and drospirenone on the concentration of leptin and ghrelin in polycystic ovary syndrome.
    Sağsöz N, Orbak Z, Noyan V, Yücel A, Uçar B, Yildiz L.
    Fertil Steril; 2009 Aug; 92(2):660-6. PubMed ID: 18973889
    [Abstract] [Full Text] [Related]

  • 2. [Serum levels of ghrelin and leptin in women with polycystic ovary syndrome].
    Pekhlivanov B, Mitkov M, Orbtsova M, Terzieva D.
    Akush Ginekol (Sofiia); 2008 Aug; 47(3):15-9. PubMed ID: 18756827
    [Abstract] [Full Text] [Related]

  • 3. Serum ghrelin level in women with polycystic ovary syndrome and its relationship with endocrine and metabolic parameters.
    Mitkov M, Pehlivanov B, Orbetzova M.
    Gynecol Endocrinol; 2008 Nov; 24(11):625-30. PubMed ID: 19031219
    [Abstract] [Full Text] [Related]

  • 4. Efficacy of an oral contraceptive containing drospirenone in the treatment of women with polycystic ovary syndrome.
    Pehlivanov B, Mitkov M.
    Eur J Contracept Reprod Health Care; 2007 Mar; 12(1):30-5. PubMed ID: 17455042
    [Abstract] [Full Text] [Related]

  • 5. Serum leptin levels correlate with clinical and biochemical indices of insulin resistance in women with polycystic ovary syndrome.
    Pehlivanov B, Mitkov M.
    Eur J Contracept Reprod Health Care; 2009 Apr; 14(2):153-9. PubMed ID: 19340711
    [Abstract] [Full Text] [Related]

  • 6. Efficacy of a new oral contraceptive containing drospirenone and ethinyl estradiol in the long-term treatment of hirsutism.
    Batukan C, Muderris II.
    Fertil Steril; 2006 Feb; 85(2):436-40. PubMed ID: 16595223
    [Abstract] [Full Text] [Related]

  • 7. Comparison of effects of 3 mg drospirenone plus 20 μg ethinyl estradiol alone or combined with metformin or cyproterone acetate on classic metabolic cardiovascular risk factors in nonobese women with polycystic ovary syndrome.
    Fruzzetti F, Perini D, Lazzarini V, Parrini D, Gambacciani M, Genazzani AR.
    Fertil Steril; 2010 Oct; 94(5):1793-8. PubMed ID: 19931080
    [Abstract] [Full Text] [Related]

  • 8. Plasma adiponectin and insulin resistance in women with polycystic ovary syndrome.
    Ardawi MS, Rouzi AA.
    Fertil Steril; 2005 Jun; 83(6):1708-16. PubMed ID: 15950640
    [Abstract] [Full Text] [Related]

  • 9. Evaluation of effects of an oral contraceptive containing ethinylestradiol combined with drospirenone on adrenal steroidogenesis in hyperandrogenic women with polycystic ovary syndrome.
    De Leo V, Morgante G, Piomboni P, Musacchio MC, Petraglia F, Cianci A.
    Fertil Steril; 2007 Jul; 88(1):113-7. PubMed ID: 17418832
    [Abstract] [Full Text] [Related]

  • 10. A comparison of oral and transdermal short-term estrogen therapy in postmenopausal women with metabolic syndrome.
    Chu MC, Cosper P, Nakhuda GS, Lobo RA.
    Fertil Steril; 2006 Dec; 86(6):1669-75. PubMed ID: 17074346
    [Abstract] [Full Text] [Related]

  • 11. Serum ghrelin, leptin and resistin levels in adolescent girls with polycystic ovary syndrome.
    Bideci A, Camurdan MO, Yeşilkaya E, Demirel F, Cinaz P.
    J Obstet Gynaecol Res; 2008 Aug; 34(4):578-84. PubMed ID: 18937712
    [Abstract] [Full Text] [Related]

  • 12. Effect of rosiglitazone on insulin resistance, growth factors, and reproductive disturbances in women with polycystic ovary syndrome.
    Belli SH, Graffigna MN, Oneto A, Otero P, Schurman L, Levalle OA.
    Fertil Steril; 2004 Mar; 81(3):624-9. PubMed ID: 15037412
    [Abstract] [Full Text] [Related]

  • 13. Serum leptin levels correlate with obesity parameters but not with hyperinsulinism in women with polycystic ovary syndrome.
    Erturk E, Kuru N, Savci V, Tuncel E, Ersoy C, Imamoglu S.
    Fertil Steril; 2004 Nov; 82(5):1364-8. PubMed ID: 15533361
    [Abstract] [Full Text] [Related]

  • 14. Basal and meal-stimulated ghrelin, PYY, CCK levels and satiety in lean women with polycystic ovary syndrome: effect of low-dose oral contraceptive.
    Arusoglu G, Koksal G, Cinar N, Tapan S, Aksoy DY, Yildiz BO.
    J Clin Endocrinol Metab; 2013 Nov; 98(11):4475-82. PubMed ID: 24001751
    [Abstract] [Full Text] [Related]

  • 15. The effects of drospirenone-ethinyl estradiol and drospirenone-ethinyl estradiol + metformin on ovarian ultrasonographic markers, body fat mass index, leptin, and ghrelin.
    Cakiroglu Y, Vural B, Isgoren S.
    Arch Gynecol Obstet; 2013 Jul; 288(1):213-20. PubMed ID: 23377194
    [Abstract] [Full Text] [Related]

  • 16. Comparative study of the therapeutic effects of oral contraceptive pills containing desogestrel, cyproterone acetate, and drospirenone in patients with polycystic ovary syndrome.
    Bhattacharya SM, Jha A.
    Fertil Steril; 2012 Oct; 98(4):1053-9. PubMed ID: 22795636
    [Abstract] [Full Text] [Related]

  • 17. Obesity, weight loss, and the polycystic ovary syndrome: effect of treatment with diet and orlistat for 24 weeks on insulin resistance and androgen levels.
    Panidis D, Farmakiotis D, Rousso D, Kourtis A, Katsikis I, Krassas G.
    Fertil Steril; 2008 Apr; 89(4):899-906. PubMed ID: 17980364
    [Abstract] [Full Text] [Related]

  • 18. Circulating leptin and ghrelin are differentially influenced by estrogen/progestin therapy and raloxifene.
    Lambrinoudaki IV, Christodoulakos GE, Economou EV, Vlachou SA, Panoulis CP, Alexandrou AP, Kouskouni EE, Creatsas GC.
    Maturitas; 2008 Jan 20; 59(1):62-71. PubMed ID: 18164562
    [Abstract] [Full Text] [Related]

  • 19. Influence of leptin, androgens and insulin sensitivity on increased GH response to clonidine in lean patients with polycystic ovary syndrome.
    Spritzer PM, Comim FV, Capp E, D'Avila A.
    Horm Metab Res; 2005 Feb 20; 37(2):94-8. PubMed ID: 15778926
    [Abstract] [Full Text] [Related]

  • 20. Effects of metformin and ethinyl estradiol-cyproterone acetate on clinical, endocrine and metabolic factors in women with polycystic ovary syndrome.
    Wu J, Zhu Y, Jiang Y, Cao Y.
    Gynecol Endocrinol; 2008 Jul 20; 24(7):392-8. PubMed ID: 18608522
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.